Glucose-Lowering Overtreatment
Cross-source consensus on Glucose-Lowering Overtreatment from 1 sources and 5 claims.
1 sources · 5 claims
Comparisons
Other
Other
Highlighted claims
- Potential overtreatment was found in 28.5% of the study cohort. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
- The study framed overtreatment as glucose-lowering medication use where harms may outweigh benefits. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
- The primary study outcome classified patients as potentially overtreated if they had two or more overlapping glucose-lowering medications or at least one insulin dispensing within 90 days after the index A1C test. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
- The observed overtreatment prevalence was consistent with prior studies but definitions vary widely. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study
- The abstract also described sulfonylurea dispensing as part of the overtreatment outcome definition. — Estimating prevalence and predictors of glucose-lowering overtreatment among older adults with type 2 diabetes in long-term care and community settings: a machine learning–based cohort study